🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and effectiveness of a...
Status
Completed
Location
University of Colorado Health Sciences Center
Start Date
2007-01
Trial ID
NCT00414518
Treatments Being Tested
The objective of this study is to establish the tipranavir-ritonavir steady...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02251132
HIV protease inhibitors (PIs) are a class of antiretroviral drugs used to i...
Status
Completed
Location
Indiana University School of Medicine
Start Date
2003-11
Trial ID
NCT00720590
Treatments Being Tested
Pharmacologic boosting of protease inhibitors with ritonavir has become sta...
Status
Completed
Location
Montefiore Medical Center
Start Date
2006-06
Trial ID
NCT00432783
Study to determine the relative bioavailability of 500/200 mg of tipranavir...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT02251158
To determine the proportion of patients whose plasma HIV-1 RNA level falls ...
Status
Completed
Location
Dr Charles Farthing
Start Date
TBD
Trial ID
NCT00002178
Treatments Being Tested
To determine the proportion of patients whose plasma HIV-1 RNA level falls ...
Status
Completed
Location
ASC Inc
Start Date
TBD
Trial ID
NCT00002378
Treatments Being Tested
The purpose of this study was to compare the safety and tolerability of the...
Status
Completed
Location
Site Reference ID/Investigator# 823
Start Date
2005-11
Trial ID
NCT00262522
Treatments Being Tested
To assess 48-week treatment responses, tolerability, and steady-state minim...
Status
Completed
Location
Bamrasnaradura Infectious Diseases Institute
Start Date
2007-04
Trial ID
NCT01002898
Treatments Being Tested